U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863987) titled 'A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents' on March 04.
Brief Summary: This study was an randomized, double-Blind, placebo-controlled, multicenter Phase II/III study.
Study Start Date: Feb. 05
Study Type: INTERVENTIONAL
Condition:
Essential Hypertension
Intervention:
DRUG: Valsartan Oral Solution
Valsartan oral solution, taken by mouth, once daily. It is recommended that the medication be administered at the same time each day (e.g., in the morning).
The dose administered is based on the subject's weight at the V1 visit:
Halve dose:
<35 kg: 7 mL (equ...